(Q37718044)

22 August 2017

1 reference

title

A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact (English)

1 reference

22 August 2017

1 reference

1

S B Jensen

1 reference

22 August 2017

A M L Pedersen

2

1 reference

22 August 2017

A Vissink

3

1 reference

22 August 2017

E Andersen

4

1 reference

22 August 2017

C G Brown

5

1 reference

22 August 2017

A N Davies

6

1 reference

22 August 2017

J Dutilh

7

1 reference

22 August 2017

J S Fulton

8

1 reference

22 August 2017

L Jankovic

9

1 reference

22 August 2017

N N F Lopes

10

1 reference

22 August 2017

A L S Mello

11

1 reference

22 August 2017

L V Muniz

12

1 reference

22 August 2017

C A Murdoch-Kinch

13

1 reference

22 August 2017

R G Nair

14

1 reference

22 August 2017

J J Napeñas

15

1 reference

22 August 2017

A Nogueira-Rodrigues

16

1 reference

22 August 2017

D Saunders

17

1 reference

22 August 2017

B Stirling

18

1 reference

22 August 2017

I von Bültzingslöwen

19

1 reference

22 August 2017

D S Weikel

20

1 reference

22 August 2017

L S Elting

21

1 reference

22 August 2017

F K L Spijkervet

22

1 reference

22 August 2017

M T Brennan

23

1 reference

22 August 2017

Salivary Gland Hypofunction/Xerostomia Section

24

1 reference

22 August 2017

Oral Care Study Group

25

1 reference

22 August 2017

Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO)

26

1 reference

22 August 2017

publication date

25 March 2010

1 reference

Supportive Care in Cancer

22 August 2017

published in

1 reference

22 August 2017

volume

18

1 reference

22 August 2017

issue

8

1 reference

22 August 2017

page(s)

1061-1079

1 reference

https://scigraph.springernature.com/pub.10.1007/s00520-010-0837-6

22 August 2017

exact match

0 references

cites work

Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Parotid-sparing radiotherapy: does it really reduce xerostomia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Parotid-sparing intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma: preserved parotid function after IMRT on quantitative salivary scintigraphy, and comparison with historical data after conventional radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Compensator-based intensity-modulated radiotherapy in head and neck cancer: our experience in achieving dosimetric parameters and their clinical correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Intensity-modulated radiotherapy for head-and-neck cancer in the community setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Can dose reduction to one parotid gland prevent xerostomia?--A feasibility study for locally advanced head and neck cancer patients treated with intensity-modulated radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and- neck cancer: 2-year follow-up of a prospective, randomized, phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Protective effect of amifostine on dental health after radiotherapy of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Effect of pilocarpine mouthwash on salivary flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Phase III quality-of-life study results: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer--RTOG 97-09.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

The effect of hyperbaric oxygen therapy on quality of life in oral and oropharyngeal cancer patients treated with radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0837-6

A double-blind, crossover study of Biotène Oralbalance and BioXtra systems as salivary substitutes in patients with post-radiotherapy xerostomia

21 January 2018

1 reference

12 December 2020

Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine

1 reference

12 December 2020

Factors influencing the parotid function in nasopharyngeal carcinoma treated with parotid-sparing radiotherapy

1 reference

12 December 2020

Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer

1 reference

12 December 2020

Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function.

1 reference

12 December 2020

Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer

1 reference

12 December 2020

Different saliva substitutes for treatment of xerostomia following radiotherapy. A prospective crossover study

1 reference

12 December 2020

World Workshop on Oral Medicine IV: Process and methodology for systematic review and developing management recommendations. Reference manual for management recommendations writing committees.

1 reference

12 December 2020

Radiation-induced hyposalivation and its treatment with oral pilocarpine.

1 reference

12 December 2020

A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients

1 reference

12 December 2020

A comparison of artificial saliva and pilocarpine in radiation-induced xerostomia

1 reference

12 December 2020

A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.

1 reference

12 December 2020

Acupuncture for pilocarpine-resistant xerostomia following radiotherapy for head and neck malignancies

1 reference

12 December 2020

Aspects of salivary gland radiosensitivity: effects of sialagogues and irradiation

1 reference

12 December 2020

Radioprotection of salivary glands by amifostine in high-dose radioiodine treatment. Results of a double-blinded, placebo-controlled study in patients with differentiated thyroid cancer

1 reference

12 December 2020

Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer

1 reference

12 December 2020

Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT

1 reference

12 December 2020

Pilocarpine in the prevention of postirradiation xerostomia

1 reference

12 December 2020

Salivary gland-sparing prophylactic pilocarpine treatment has no effect on tumor regrowth after irradiation

1 reference

12 December 2020

Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques

1 reference

12 December 2020

Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma

1 reference

12 December 2020

Oral complications of cancer therapies. Pretherapy interventions to modify salivary dysfunction

1 reference

12 December 2020

Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction

1 reference

12 December 2020

Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy

1 reference

12 December 2020

Pilocarpine hydrochloride for symptomatic relief of xerostomia due to chronic graft-versus-host disease or total-body irradiation after bone-marrow transplantation for hematologic malignancies

1 reference

12 December 2020

A double-blind crossover trial of Oral Balance gel and Biotene toothpaste versus placebo in patients with xerostomia following radiation therapy

1 reference

12 December 2020

Manual acupuncture improved quality of life in cancer patients with radiation-induced xerostomia

1 reference

12 December 2020

The efficacy of Xialine in patients with xerostomia resulting from radiotherapy for head and neck cancer: a pilot-study

1 reference

12 December 2020

A double-blind cross-over trial of a mucin-containing artificial saliva

1 reference

12 December 2020

Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy

1 reference

12 December 2020

Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia

1 reference

12 December 2020

American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants

1 reference

12 December 2020

Upfront submandibular salivary gland transfer in pharyngeal cancers

1 reference

12 December 2020

Long-term follow-up of patients treated with acupuncture for xerostomia and the influence of additional treatment

1 reference

12 December 2020

Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience

1 reference

12 December 2020

Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia

1 reference

12 December 2020

Alpha-adrenergic stimulation and radiosensitivity on the rat submaxillary gland

1 reference

12 December 2020

A single institution experience with pediatric nasopharyngeal carcinoma: high incidence of toxicity associated with platinum-based chemotherapy plus IMRT.

1 reference

12 December 2020

Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer

1 reference

12 December 2020

A multicenter maintenance study of oral pilocarpine tablets for radiation-induced xerostomia

1 reference

12 December 2020

Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study

1 reference

12 December 2020

Effect of oral pilocarpine on post-irradiation xerostomia in head and neck cancer patients: a single-center, single-blind clinical trial

1 reference

12 December 2020

Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia

1 reference

12 December 2020

Short-Term Radioprotective Effects of WR-2721 on the Rat Parotid Glands

1 reference

12 December 2020

3D-conformal-intensity modulated radiotherapy with compensators for head and neck cancer: clinical results of normal tissue sparing

1 reference

12 December 2020

Pilocarpine treatment in a mixed cohort of xerostomic patients

1 reference

12 December 2020

The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy

1 reference

12 December 2020

Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancer

1 reference

12 December 2020

Comparison of the effect of the linseed extract Salinum and a methyl cellulose preparation on the symptoms of dry mouth

1 reference

12 December 2020

National Institutes of Health Consensus Development Conference on Oral Complications of Cancer Therapies: Diagnosis, Prevention, and Treatment. Bethesda, Maryland, April 17-19, 1989

1 reference

12 December 2020

A pilot study of Salix SST (saliva-stimulating lozenges) in post-irradiation xerostomia

1 reference

12 December 2020

Xerostomia--clinical evaluation and treatment in general practice

1 reference

12 December 2020

IMRT with the use of simultaneous integrated boost in treatment of head and neck cancer: acute toxicity evaluation

1 reference

12 December 2020

Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia

1 reference

12 December 2020

Determination of the efficacy of topical oral pilocarpine for postirradiation xerostomia in patients with head and neck carcinoma

1 reference

12 December 2020

Effectiveness of pilocarpine in postradiation xerostomia

1 reference

12 December 2020

Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience

1 reference

12 December 2020

Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?

1 reference

12 December 2020

Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis

1 reference

12 December 2020

A double-blind crossover trial of CMC- and mucin-containing saliva substitutes

1 reference

12 December 2020

A clinical comparison between commercially available mucin- and CMC-containing saliva substitutes

1 reference

12 December 2020

Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia).

1 reference

12 December 2020

A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life

1 reference

12 December 2020

Effect of radiation techniques in treatment of oropharynx cancer

1 reference

12 December 2020

Efficacy of pilocarpine lozenge for post-radiation xerostomia in patients with head and neck cancer.

1 reference

12 December 2020

The effect of Salinum on the symptoms of dry mouth: a pilot study

1 reference

12 December 2020

Phase III randomized trial of amifostine as a radioprotector in head and neck cancer

1 reference

12 December 2020

The role of submandibular salivary gland transfer in preventing xerostomia in the chemoradiotherapy patient

1 reference

12 December 2020

Reducing the incidence of 131I-induced sialadenitis: the role of pilocarpine

1 reference

12 December 2020

The efficacy of mucin-containing artificial saliva in alleviating symptoms of xerostomia

1 reference

12 December 2020

Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia.

1 reference

12 December 2020

A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results

1 reference

12 December 2020

Clinical study of the radioprotective effects of Amifostine (YM-08310, WR-2721) on chronic radiation injury

1 reference

12 December 2020

Assessment of xerostomia and its impact on quality of life in head and neck cancer patients undergoing radiotherapy, and validation of the Taiwanese version of the xerostomia questionnaire.

1 reference

12 December 2020

Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume

1 reference

12 December 2020

Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer

1 reference

12 December 2020

Assessment of salivary function change in nasopharyngeal carcinoma treated by parotid-sparing radiotherapy

1 reference

12 December 2020

Oral complications of cancer therapies: diagnosis, prevention, and treatment

1 reference

12 December 2020

Effect of Amifostine to prevent radiotherapy-induced acute and late toxicity in head and neck cancer patients who had normal or mild impaired salivary gland function.

1 reference

12 December 2020

Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial

1 reference

12 December 2020

Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients.

1 reference

12 December 2020

Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life

1 reference

12 December 2020

Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report

1 reference

12 December 2020

Impact on cytoprotective efficacy of intermediate interval between amifostine administration and radiotherapy: a retrospective analysis

1 reference

12 December 2020

Effects of sucking acidic candies on saliva in unilaterally irradiated pharyngeal cancer patients

1 reference

12 December 2020

A saliva substitute for use by xerostomic patients undergoing radiotherapy to the head and neck

1 reference

12 December 2020

Controlled study of lactoperoxidase gel on oral flora and saliva in irradiated patients with oral cancer

1 reference

12 December 2020

Treatment of xerostomia following radiotherapy: does age matter?

1 reference

12 December 2020

Impact of perioperative hyperbaric oxygen therapy on the quality of life of maxillofacial patients who undergo surgery in irradiated fields.

1 reference

12 December 2020

Aquaporin-1 gene transfer to correct radiation-induced salivary hypofunction

1 reference

12 December 2020

Radioprotection by WR-2721 against Long-Term Chronic Damage to the Rat Parotid Gland

1 reference

12 December 2020

A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma

1 reference

12 December 2020

Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia

1 reference

12 December 2020

Late xerostomia after intensity-modulated radiation therapy versus conventional radiotherapy

1 reference

12 December 2020

Favourable impact of intensity-modulated radiation therapy on chronic dysphagia in patients with head and neck cancer

1 reference

12 December 2020

A randomized trial of amifostine as radioprotector in the radiotherapy of head and neck cancer

1 reference

12 December 2020

Influence of amifostine on late radiation-toxicity in head and neck cancer--a follow-up study

1 reference

12 December 2020

A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer

1 reference

12 December 2020

Salivary scintigraphy for assessing the protective effect of pilocarpine in head and neck irradiated tumours

1 reference

12 December 2020

Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer

1 reference

12 December 2020

Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy

1 reference

12 December 2020

A clinical comparative trial of saliva substitutes in radiation-induced salivary gland hypofunction

1 reference

12 December 2020

Distribution of 35 S-Labeled WR-2721 in Normal and Malignant Tissues of the Mouse

1 reference

12 December 2020

Rheological properties of saliva substitutes containing mucin, carboxymethylcellulose or polyethylenoxide

1 reference

12 December 2020

Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of concomitant pilocarpine with head and neck irradiation for prevention of radiation-induced xerostomia.

1 reference

12 December 2020

Morphologic and histochemical studies on the differing radiosensitivity of ductular and acinar cells of the rat submandibular gland

1 reference

12 December 2020

Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients

1 reference

12 December 2020

Acupuncture treatment of patients with radiation-induced xerostomia

1 reference

12 December 2020

Stem cell therapy to reduce radiation-induced normal tissue damage

1 reference

12 December 2020

Efficacy of the BioXtra dry mouth care system in the treatment of radiotherapy-induced xerostomia.

1 reference

12 December 2020

Feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated concomitant-boost radiation therapy

1 reference

12 December 2020

Pilocarpine for the treatment of salivary glands' impairment caused by radioiodine therapy for thyroid cancer

1 reference

12 December 2020

The effect of mucin-containing artificial saliva on severe xerostomia

1 reference

12 December 2020

Wetting properties of human saliva and saliva substitutes

1 reference

12 December 2020

Synthetic saliva in the treatment of hyposialies, especially in radiation sialadenitis

1 reference

12 December 2020

Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space

1 reference

12 December 2020

The efficacy of pilocarpine and bethanechol upon saliva production in cancer patients with hyposalivation following radiation therapy

1 reference

12 December 2020

Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study

1 reference

12 December 2020

Does amifostine have a role in chemoradiation treatment?

1 reference

12 December 2020

Long-term outcomes of submandibular gland transfer for prevention of postradiation xerostomia

1 reference

12 December 2020

Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: comparisons of four radiotherapy techniques.

1 reference

12 December 2020

10.1007/S00520-010-0837-6

Identifiers

DOI

1 reference

22 August 2017

1 reference